WallStSmart
TXMD

TherapeuticsMD Inc

NASDAQ: TXMD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$2.04
-3.32% today

Updated 2026-04-30

Market cap
$24.31M
P/E ratio
P/S ratio
8.04x
EPS (TTM)
$-0.06
Dividend yield
52W range
$1 – $3
Volume
0.0M

TherapeuticsMD Inc (TXMD) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$329840.00$344098.00$-133003.00$-417338.00$836832.00$-4.97M$-12.74M$-20.77M$-45.52M$-79.04M$-69.14M$-76.16M$-106.81M$-165.70M$-159.47M$-147.81M$-4.08M$-48.14M$732000.00$2.45M
Capital expenditures$57746.00$0.00$0.00$841296.00$0.00$37636.00$272506.00$479824.00$617442.00$584361.00$1.24M$827108.00$21.32M$23.89M$1.60M$34000.00$355000.00$48.14M$0.00$0.00
Depreciation$54368.00$76203.00$61383.00$54845.00$56260.00$58145.00$52467.00$62400.00$132451.00$213117.00$293886.00$1.39M$4.07M$736000.00$1.19M$922000.00$509000.00
Stock-based comp$7.79M$1.87M$3.21M$4.24M$7.19M$17.41M$6.89M$8.66M$10.68M$10.68M$18.13M$11.57M$1.27M$264000.00$75000.00
Free cash flow$272094.00$344098.00$-133003.00$-1.26M$836832.00$-5.00M$-13.01M$-21.25M$-46.14M$-79.63M$-70.38M$-76.98M$-128.13M$-189.59M$-161.07M$-147.84M$-4.43M$-96.28M$732000.00$2.45M
Investing cash flow$54254.00$22756.00$-841296.00$-285500.00$-37636.00$-272506.00$-583561.00$-606756.00$-584361.00$-1.26M$-827108.00$-21.50M$-23.91M$-1.60M$-2.22M$223.48M
Financing cash flow$-300622.00$-943949.00$-221212.00$1.30M$-550000.00$4.71M$14.44M$73.99M$43.30M$92.97M$137.23M$72.58M$162.79M$188.83M$80.72M$134.67M$-235.21M$3.15M$0.00
Dividends paid$174642.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$-296518.00$1.43M$52.64M$-2.83M$13.34M$66.83M$-4.40M$34.48M$-80.34M$-15.36M